-Translation- Ref. EIC-AD017/2018 May 15, 2018 Subject: Management Discussion and Analysis for the Quarterly Performance Ending March 31, 2018 To: President The Stock Exchange of Thailand Reference is made to
- Translation – Ref. EIC-AD035/2018 November 13, 2018 Subject Management Discussion and Analysis for the Six-Month Period Performance Ending September 30, 2018 To President The Stock Exchange of Thailand The
(Translation) NEP-AC 002/2563 14 May 2020 Subject: Management Discussion and Analysis for Q1 end of 31 March 2020 To : The President The Stock Exchange of Thailand Operating Result NEP Realty and
ที่บชง Page 1 of 4 Ref. Bor Chor Ngor 0268/2020 10 August 2020 Subject: Management Discussion and Analysis for the Second Quarter ended 30 June 2020 To President The Stock Exchange of Thailand
, 2020 Subject Management’ Discussion and Analysis for the 1st Quarter in 2020 To Directors & Managers The Stock Exchange of Thailand Inter Pharma Public Company Limited (“the Company”) hereby submitting
-1- AIT (VP-SEC) 025E/2023 August 10, 2023 Subject: Management's Discussion and Analysis of Operating Results for Q2-2023 To: The President of the Stock Exchange of Thailand Summary of Operations Q2
Ref. MD 115/2017 August 28, 2017 Re: Clarification on the Financial Performance of the Company and its subsidiaries as of Year 2016 (amendment) Attn: President The Stock Exchange of Thailand We, K. C
Management Discussion and Analysis 1 Ref: AC.017/2020 18 May 2020 Subject: Management discussion and analysis of financial position and operating results To: President and Manager The Stock Exchange
%. Delivered FY20 performance in-line with guidance from well-managed cost Overall FY20 performance tracked in- line with all guidance. Core serviced revenue of Bt129,594mn declined -5.1%YoY vs guidance of low